Vitamin C injections slow tumor growth in mice

August 4, 2008

High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the Proceedings of the National Academy of Sciences. The researchers traced ascorbate's anti-cancer effect to the formation of hydrogen peroxide in the extracellular fluid surrounding the tumors. Normal cells were unaffected.

Natural physiologic controls precisely regulate the amount of ascorbate absorbed by the body when it is taken orally. "When you eat foods containing more than 200 milligrams of vitamin C a day--for example, 2 oranges and a serving of broccoli--your body prevents blood levels of ascorbate from exceeding a narrow range," says Mark Levine, M.D., the study's lead author and chief of the Molecular and Clinical Nutrition Section of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the NIH.

To bypass these normal controls, NIH scientists injected ascorbate into the veins or abdominal cavities of rodents with aggressive brain, ovarian, and pancreatic tumors. By doing so, they were able to deliver high doses of ascorbate, up to 4 grams per kilogram of body weight daily. "At these high injected doses, we hoped to see drug-like activity that might be useful in cancer treatment," said Levine.

Vitamin C plays a critical role in health, and a prolonged deficiency leads to scurvy and eventually to death. Some proteins known as enzymes, which have vital biochemical functions, require the vitamin to work properly. Vitamin C may also act as an antioxidant, protecting cells from the damaging effects of free radicals. The NIH researchers, however, tested the idea that ascorbate, when injected at high doses, may have prooxidant instead of antioxidant activity. Prooxidants would generate free radicals and the formation of hydrogen peroxide, which, the scientists hypothesized, might kill tumor cells. In their laboratory experiments on 43 cancer and 5 normal cell lines, the researchers discovered that high concentrations of ascorbate had anticancer effects in 75 percent of cancer cell lines tested, while sparing normal cells. In their paper, the researchers also showed that these high ascorbate concentrations could be achieved in people.

The team then tested ascorbate injections in immune-deficient mice with rapidly spreading ovarian, pancreatic, and glioblastoma (brain) tumors. The ascorbate injections reduced tumor growth and weight by 41 to 53 percent. In 30 percent of glioblastoma controls, the cancer had spread to other organs, but the ascorbate-treated animals had no signs of disseminated cancer. "These pre-clinical data provide the first firm basis for advancing pharmacologic ascorbate in cancer treatment in humans," the researchers conclude.

Interest in vitamin C as a potential cancer therapy peaked about 30 years ago when case series data showed a possible benefit. In 1979 and 1985, however, other researchers reported no benefit for cancer patients taking high oral doses of vitamin C in two double-blind, placebo-controlled clinical trials.

Several observations led the NIH researchers to revisit ascorbate as a cancer therapy. "Clinical and pharmacokinetic studies conducted in the past 12 years showed that oral ascorbate levels in plasma and tissue are tightly controlled. In the case series, ascorbate was given orally and intravenously, but in the trials ascorbate was just given orally. It was not realized at the time that only injected ascorbate might deliver the concentrations needed to see an anti-tumor effect," said Levine, who noted that new clinical trials of ascorbate as a cancer treatment are in the planning stages.

Data from Levine's earlier studies of the regulation and absorption of dietary vitamin C were used in the revision of the Institute of Medicine's Recommended Dietary Allowance for the vitamin in 2000. In the current study, Levine led a team of scientists from the NIDDK and the National Cancer Institute (NCI), both components of the NIH, as well as the University of Kansas. "NIH's unique translational environment, where researchers can pursue intellectual high-risk, out-of-the-box thinking with high potential payoff, enabled us to pursue this work," he said.

Source: National Institute of Diabetes and Digestive and Kidney Diseases

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

irjsi
Aug 04, 2008

Rank: 5 / 5 (1)
How can terminal patients access "C"
injections?
Benign side effects would be little
deterrent to one with a diminishing
time frame!
Also, administer ASAP post-diagnosis;
prior to debilitating effects resulting
from current treatment regimen.
Roy Stewart,
Phoenix AZ
E_L_Earnhardt
Aug 05, 2008

Rank: 1 / 5 (1)
I'll bet "COOL WATER" would do the same! Tap off the ENERGY and you slow mitosis! Nevertheless, USE it! ANYTHING THAT WORKS!
Northerntracey
Aug 13, 2008

Rank: 5 / 5 (1)
I am amazed at the gall of the media. Not only this paper but all the other touting this so-called "breakthrough research". It has been well known for many years that intravenous VitC can save cancer patients lives. Clinical trials? No need. Just visit some of the many banned clinics ousted from America to Mexico where they have been saving lives for years. Where were the papers then. How many more lives could have been saved if not for the media blackout of many other 'alternative' therapies that work like DMSO, MMS, Becks protocol, Gerson Therapy etc etc.
It's about time people woke up to what is going on with the whole medical 'racket'.
And what now of the proposed ban on VitC supplements in Canada coming from Codex?
Or is that all part of another plan for profits to Big Pharma?
Rank 5 /5 (25 votes)
Tags

Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...

Medicine & Health / Neuroscience

created 11 hours ago | popularity 4.9 / 5 (32) | comments 14 | with audio podcast

Anyone can learn to be more inventive, cognitive researcher says

There will always be a wild and unpredictable quality to creativity and invention, says Anthony McCaffrey, a cognitive psychology researcher at the University of Massachusetts Amherst, because an "Aha moment" is rare and ...

Medicine & Health / Psychology & Psychiatry

created 7 hours ago | popularity 4.8 / 5 (5) | comments 0 | with audio podcast

Cell biologists describes mechanism by which some people may be more susceptible to colon cancer

An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United ...

Medicine & Health / Cancer

created 7 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Researchers weigh in on ethics of H5N1 research

(Medical Xpress) -- In a commentary on the biosecurity controversy surrounding publication of bird flu research details, a bioethicist and a vaccine expert at Johns Hopkins reaffirm that "all scientists have an affirmativ ...

Medicine & Health / Other

created 9 hours ago | popularity not rated yet | comments 0 | with audio podcast

To perform with less effort, practice beyond perfection

Whether you are an athlete, a musician or a stroke patient learning to walk again, practice can make perfect, but more practice may make you more efficient, according to a surprising new University of Colorado Boulder study.

Medicine & Health / Neuroscience

created 10 hours ago | popularity 4.5 / 5 (8) | comments 3 | with audio podcast


'Dark plasmons' transmit energy

Microscopic channels of gold nanoparticles have the ability to transmit electromagnetic energy that starts as light and propagates via "dark plasmons," according to researchers at Rice University.

Hydrogen from acidic water: Researchers develop potential low cost alternative to platinum for splitting water

A technique for creating a new molecule that structurally and chemically replicates the active part of the widely used industrial catalyst molybdenite has been developed by researchers with the Lawrence Berkeley ...

Ultraviolet protection molecule in plants yields its secrets

Lying around in the sun all day is hazardous not just for humans but also for plants, which have no means of escape. Ultraviolet (UV) radiation from the sun can damage proteins and DNA inside cells, leading ...

New method makes culture of complex tissue possible in any lab

Scientists at the University of California, San Diego have developed a new method for making scaffolds for culturing tissue in three-dimensional arrangements that mimic those in the body. This advance, published online in ...

Flexible paper robots

(PhysOrg.com) -- These inexpensive robots can stretch, bend and twist under control, and lift objects up to 120 times their own weight. Being soft, they can apply gentle and even pressure, and adapt to varied ...

Soraa LED light may dim 50-watt halogen rivals

(PhysOrg.com) -- Soraa, a Fremont, California company founded in 2008, this week launched its first product, a light that uses LEDS (light emitting diodes). The "Soraa LED MR16 lamp" is the "perfect" replacement ...